Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Mice with autoimmune hair loss showed signs of heart problems.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Sex hormones do not cause oral lichen planus.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.